CellmAbs
Lisbon
About CellmAbs
CellmAbs is a NOVA University of Lisbon spin-off company that was founded in 2019 with the funding of two of Portugal's top Life Science Venture Capital firms. CellmAbs is a rapidly expanding biotech firm with an international, experienced team that has developed multiple preclinical candidates targeting solid tumors based on a world-class understanding of cancer-specific glycan targets.v
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Seed (Jun 2019)
- Website: cellmabs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/cellmabs-155549 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.